返回返回EVROFARMA S.A. (CR)的普通股股東可獲得的稀釋淨收入。
年度數據
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2022
2023
TTM
0.00
600.00 K
1.20 M
1.80 M
2.40 M
2023
2.20 M
+783.00 K
+55.18%
2022
1.42 M
+339.00 K
+31.39%
2020
1.08 M
+923.00 K
+587.90%
2019
157.00 K
−822.00 K
−83.96%
2018
979.00 K
+443.00 K
+82.65%
半年度數據
H2 '16
H1 '17
H2 '17
H1 '18
H2 '18
H1 '19
H2 '19
H1 '20
H2 '20
H1 '21
H1 '24
0.00
400.00 K
800.00 K
1.20 M
1.60 M
H1 '24
1.40 M
+741.00 K
+112.27%
H1 '21
660.00 K
−82.00 K
−11.05%
H2 '20
742.00 K
+404.00 K
+119.53%
H1 '20
338.00 K
+402.00 K
—